Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine

Clinical trial NCT03160820 · COMPLETED

Trial details

NCT number: NCT03160820
Sponsor: Centers for Disease Control and Prevention, China
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Measles Mumps Rubella Adverse Event Following Immunisation

Start date: 2016-03-01
Primary completion: 2016-12-01
Enrollment: 873

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.